2026 Bangladesh Measles Epidemic: A Result of Policy and Procurement Errors
In August 2026, Bangladesh faced a sharp increase in measles cases that health experts now trace back to a series of policy and procurement errors. The Global Center for Democratic Governance (GCDG) released a detailed briefing titled "Preventable Tragedy: Bangladesh’s 2026 Measles Outbreak," concluding that the crisis could have been averted with proper vaccination coverage.
During the 2024‑2025 interim rule of Mohammad Yunus, the government replaced the UNICEF‑managed supply chain with an open tender for vaccine acquisition. UNICEF issued multiple alerts between 2024 and 2026, warning of potential shortages, yet the tender’s drawn‑out negotiations prevented timely purchases. Only 17.8 million doses were secured for the August‑November 2025 window, far short of the roughly 70 million doses required each year for routine immunisation.
EPI statistics reveal that measles vaccination coverage fell to 56.2 percent in 2025, the lowest level since 2017. The World Health Organization later confirmed that a complete depletion of MR vaccine stocks nationwide, coupled with the suspension of supplementary immunisation activities, left large numbers of children unprotected, fueling the 2026 outbreak.
GCDG’s analysis lists the following systemic failures: delayed procurement, logistical hurdles, exhausted vaccine inventories, cancelled outreach sessions, reduced MR1/MR2 coverage, a growing pool of under‑vaccinated children, and an inadequate emergency health response from the current Bangladesh Nationalist Party administration. The report also criticises the lack of transparent information sharing during the crisis, labeling it a separate and serious shortcoming.
